Issue 4 - August 2010 - Pacini Editore
Issue 4 - August 2010 - Pacini Editore
Issue 4 - August 2010 - Pacini Editore
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
140<br />
concerning the diagnosis of sinonasal undifferentiated and<br />
poorly differentiated carcinomas, neuroendocrine carcinoma<br />
and olfactory neuroblastoma.<br />
Sinonasal poorly differentiated and undifferentiated<br />
carcinomas<br />
The group of high grade poorly differentiated and undifferentiated<br />
sinonasal carcinomas include nasopharyngeal-type<br />
undifferentiated carcinoma (lymphoepithelioma), sinonasal<br />
undifferentiated carcinoma (SNUC), NUT midline carcinoma,<br />
and poorly differentiated keratinizing and non-keratinizing<br />
variants of squamous cell carcinoma.<br />
Nasopharyngeal-type undifferentiated carcinoma is typically<br />
associated with EBV infection, and this is a useful feature<br />
to separate this entity from other sinonasal undifferentiated<br />
carcinomas, which are typically EBV negative 1 .<br />
SNUC is a rare highly aggressive tumour of uncertain histogenesis.<br />
The term “undifferentiated” has been applied inconsistently<br />
in the past, but should now be applied more selectively<br />
with better methods of cell study. By definition SNUC<br />
does not show any overt squamous or glandular differentiation,<br />
whereas neuroendocrine features have been frequently<br />
noted, both histologically and immunohistochemically 2 .<br />
SNUC can be distinguished from poorly differentiated<br />
squamous cell carcinoma variants for the different pattern<br />
of cytokeratins subtypes expression, since SNUC is positive<br />
for simple epithelia cytokeratins and lacks the expression<br />
of cytokeratins 5/6 and 13, which instead are expressed by<br />
squamous cell carcinoma variants 3 . In addition, SNUC has a<br />
limited expression of p63, which is present in squamous cell<br />
carcinoma variants 4 .<br />
NUT midline carcinoma (NMC) is a rare, clinically aggressive<br />
carcinoma, which is defined by a translocation involving<br />
the NUT (nuclear protein in testis) gene on chromosome<br />
15q14 and, in most cases, the BRD4 gene on chromosome<br />
19p13.1. Initial cases were reported in young patients affected<br />
by intrathoracic carcinomas, but it is now well established<br />
that these tumours may occur in adults and involve<br />
other anatomic sites, including the sinonasal tract 5 . So far<br />
less than ten cases have been described in the nasal cavity<br />
and paranasal sinuses. These tumours affected young adults<br />
of both sexes and showed an aggressive clinical behaviour.<br />
However, there is certainly an underestimation of their occurrence<br />
due to the lack of specific diagnostic features.<br />
Histologically, these carcinomas are composed of undifferentiated<br />
basaloid cells with focal, often abrupt, squamous<br />
differentiation. Therefore, the diagnosis of NMC requires<br />
the demonstration of the NUT translocation, which can be<br />
achieved by karyotyping, reverse transcription polymerase<br />
chain reaction (RT-PCR), and FISH. Recently, a monoclonal<br />
antibody to NUT has been developed, which showed a sensitivity<br />
of 87%, a specificity of 100%, a negative predictive<br />
value of 99%, and a positive predictive value of 100% when<br />
tested in a large panel of carcinoma tissues 6 . Moreover, the<br />
expression of normal NUT protein is limited to the germ cells<br />
of the testis and ovary, thus increasing the reliability of the<br />
use of immunohistochemistry in the diagnosis of NMC. The<br />
use of this antibody may help to separate NMC from other<br />
poorly differentiated sinonasal carcinomas, thus contributing<br />
to their clinico-pathologic characterisation. In addition,<br />
it appears that the distinction of NMC from other sinonasal<br />
carcinomas is of clinical relevance, in view of the favourable<br />
response to certain treatment regimes, including chemotherapy<br />
according to Ewing’s sarcoma protocols 7 or docetaxel<br />
and radiotherapy 8 .<br />
5 th triennial congress of the italian society of anatomic Pathology and diagnostic cytoPathology<br />
Small cell carcinoma, neuroendocrine type (SCC-<br />
NET)<br />
Currently, WHO classification of head & neck tumours,<br />
places SCCNET in the category of neuroendocrine tumours<br />
together with carcinoid tumour, which can be further sub-classified<br />
into typical and atypical 9 . SCCNET of the nasal cavities<br />
and paranasal sinuses is a very uncommon neoplasm of which<br />
only small series and isolate case reports have been reported<br />
in the English literature 10 . A critical review of these reports<br />
reveals that in some cases the clinico-pathological features<br />
of the lesions described were more consistent with other diagnoses,<br />
including olfactory neuroblastoma and SNUC. This<br />
underlines the current lack of criteria, including a definition<br />
of a panel of immunohistochemical markers, to make the diagnosis<br />
of SCCNET. Small cell neuroendocrine carcinoma of<br />
the sinonasal tract is histologically indistinguishable from its<br />
pulmonary counterpart. Immunohistochemically, it is positive<br />
for cytokeratins and neuroendocrine markers such as NSE<br />
(neuron specific enolase), synaptophysin, and chromogranin,<br />
although with variable intensity 10 . As small cell neuroendocrine<br />
carcinomas of other sites, sinonasal tumours express<br />
CD57 11 . These features allow the distinction from SNUC,<br />
malignant melanoma, olfactory neuroblastoma, lymphoma,<br />
Ewing’s sarcoma/PNET and rhabdomyosarcoma.<br />
Olfactory Neuroblastoma (ON)<br />
ON is a rare neoplasm occurring in a broad age range, which<br />
most commonly originates in the region of the cribriform plate<br />
from the olfactory mucosa 12 . More frequently, the tumour<br />
grows in nests separated by fibrovascular septa, or sometimes<br />
it may show a diffuse growth pattern. The neoplastic cells<br />
typically have small and round nuclei with stippled chromatin,<br />
absent or small nucleoli, and scanty cytoplasm. They are<br />
embedded in a fibrillary background formed by cell processes.<br />
Homer-Wright type of rosettes, or more rarely Flexner rosettes<br />
can be found. Immunohistochemically, ON shows diffuse<br />
positivity for NSE and synaptophysin, while chromogranin,<br />
GFAP and leu-7 are less often positive. S-100 protein stains<br />
sustentacular cells around neoplastic nests, but in less differentiated<br />
tumours there may be few scattered S-100 protein<br />
positive cells. Neurofilament protein and other markers of neural<br />
differentiation are more often expressed in tumours with<br />
diffuse, sheet-like pattern. Cytokeratins are generally negative,<br />
although in ON with nesting pattern a few tumours cells may<br />
exhibit staining for low molecular weight cytokeratins. A subgroup<br />
of ON with gland-like formations and more widespread<br />
cytokeratin positivity has been designated “olfactory neuroepithelioma”<br />
13 . EMA is consistently negative, as they are CD99,<br />
CD45, HMB-45 and muscle markers. Ultrastructural analysis<br />
shows evidence of neuroblastic differentiation, including the<br />
presence of dendritic processes containing dense core granules<br />
and neurotubules, and occasional synaptic junctions. ON lacks<br />
the t(11; 22) translocation of Ewing’s sarcoma/PNET.<br />
references<br />
1 Cerilli LA, Holst VA, Brandwein MS, et al. Sinonasal undifferentiated<br />
carcinoma: immunohistochemical profile and lack of EBV association.<br />
Am J Surg Pathol 2001;25:156-63.<br />
2 Mills SE. Neuroectodermal neoplasms of the head and neck with emphasis<br />
on neuroendocrine carcinomas. Mod Pathol 2002;15:264-78.<br />
3 Franchi A, Moroni M, Massi D, et al. Sinonasal undifferentiated carcinoma,<br />
nasopharyngeal-type undifferentiated carcinoma, and keratinizing<br />
and nonkeratinizing squamous cell carcinoma express different<br />
cytokeratin patterns. Am J Surg Pathol 2002;26:1597-604.<br />
4 Bourne TD, Bellizzi AM, Stelow EB, et al. p63 expression in olfactory<br />
neuroblastoma and other small cell tumors of the sinonasal tract. Am<br />
J Clin Pathol 2008;130:213-8.